KIREPORTS

Written by Cristina Popa MD Reviewed by Sophia Ambruso MD A woman is three days postpartum. Her platelet count is falling, creatinine is rising, and the peripheral blood smear shows schistocytes. The laboratory phenotype is unmistakably thrombotic microangiopathy (TMA); the underlying diagnosis is not. HELLP syndrome, thrombotic thrombocytopenic purpura (TTP), and complement-mediated atypical hemolytic uremic syndrome (aHUS) can initially produce remarkably similar clinical

Telitacicept in Posttransplant IgA Nephropathy, does this change how we think about the disease in the transplant patient?

Obinutuzumab offers a promising next-generation therapy for rituximab-resistant membranous nephropathy, achieving high remission rates and durable B-cell depletion.